79 related articles for article (PubMed ID: 23032825)
1. Clinicopathological spectrum of 19 adenosarcomas of female genital tract, including uncommon clinical associations and immunohistochemical profile, reviewed at a single institution.
Rekhi B; Deodhar KK; Maheshwari A; Menon S; Kerkar R; Bajpai J; Ghosh J; Gupta S; Engineer R; Shrivastava SK
Indian J Pathol Microbiol; 2012; 55(3):326-32. PubMed ID: 23032825
[TBL] [Abstract][Full Text] [Related]
2. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.
Gallardo A; Prat J
Am J Surg Pathol; 2009 Feb; 33(2):278-88. PubMed ID: 18941402
[TBL] [Abstract][Full Text] [Related]
3. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
Soslow RA; Ali A; Oliva E
Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
[TBL] [Abstract][Full Text] [Related]
4. CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma.
Van Mieghem T; Abeler VM; Moerman P; Verbist L; Vergote I; Amant F
Gynecol Oncol; 2005 Nov; 99(2):493-6. PubMed ID: 16051333
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
6. Mullerian adenosarcoma of the female genital tract.
McCluggage WG
Adv Anat Pathol; 2010 Mar; 17(2):122-9. PubMed ID: 20179434
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.
Amant F; Schurmans K; Steenkiste E; Verbist L; Abeler VM; Tulunay G; De Jonge E; Massuger L; Moerman P; Vergote I
Gynecol Oncol; 2004 Jun; 93(3):680-5. PubMed ID: 15196864
[TBL] [Abstract][Full Text] [Related]
8. The Impact on Survival of an Extensive Sex Cord-like Component in Mullerian Adenosarcomas: A Study Comprising 6 Cases.
Stolnicu S; Molnar C; Barsan I; Boros M; Nogales FF; Soslow RA
Int J Gynecol Pathol; 2016 Mar; 35(2):147-52. PubMed ID: 26535983
[TBL] [Abstract][Full Text] [Related]
9. Cellular angiofibroma and related fibromatous lesions of the vulva: report of a series of cases with a morphological spectrum wider than previously described.
McCluggage WG; Ganesan R; Hirschowitz L; Rollason TP
Histopathology; 2004 Oct; 45(4):360-8. PubMed ID: 15469474
[TBL] [Abstract][Full Text] [Related]
10. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.
Friedlander ML; Covens A; Glasspool RM; Hilpert F; Kristensen G; Kwon S; Selle F; Small W; Witteveen E; Russell P
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S78-82. PubMed ID: 25341585
[TBL] [Abstract][Full Text] [Related]
11. High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior.
Hodgson A; Amemiya Y; Seth A; Djordjevic B; Parra-Herran C
Am J Surg Pathol; 2017 Nov; 41(11):1513-1522. PubMed ID: 28834809
[TBL] [Abstract][Full Text] [Related]
12. Management of uterine adenosarcomas with and without sarcomatous overgrowth.
Tanner EJ; Toussaint T; Leitao MM; Hensley ML; Soslow RA; Gardner GJ; Jewell EL
Gynecol Oncol; 2013 Apr; 129(1):140-4. PubMed ID: 23283300
[TBL] [Abstract][Full Text] [Related]
13. Adenosarcomas originating from sites other than uterine endometrium.
Inoue M; Fukuda H; Tanizawa O
Int J Gynaecol Obstet; 1995 Mar; 48(3):299-306. PubMed ID: 7781874
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite Instability Status and the Expression of p16 and Cyclin D1 Proteins in Uterine Adenosarcoma and Their Clinicopathological Significance.
Atilgan AO; Akcay EY; Ozen O; Haberal Reyhan AN; Ayhan A
Turk Patoloji Derg; 2023; 39(1):31-41. PubMed ID: 35876683
[TBL] [Abstract][Full Text] [Related]
15. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
Middleton LP; Amin M; Gwyn K; Theriault R; Sahin A
Cancer; 2003 Sep; 98(5):1055-60. PubMed ID: 12942575
[TBL] [Abstract][Full Text] [Related]
16. Endometrial stromal lesions: a morphological and immunohistochemical study of short series.
Bal A; Mohan H; Aulakh R; Huria A
Arch Gynecol Obstet; 2008 Jan; 277(1):21-4. PubMed ID: 17619891
[TBL] [Abstract][Full Text] [Related]
17. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
[TBL] [Abstract][Full Text] [Related]
18. Uterine adenosarcomas overgrown by sex-cord-like tumour: report of two cases.
Stolnicu S; Balachandran K; Aleykutty MA; Loghin A; Preda O; Goez E; Nogales FF
J Clin Pathol; 2009 Oct; 62(10):942-4. PubMed ID: 19783725
[TBL] [Abstract][Full Text] [Related]
19. Mesodermal (müllerian) adenosarcoma of the ovary: a clinicopathologic analysis of 40 cases and a review of the literature.
Eichhorn JH; Young RH; Clement PB; Scully RE
Am J Surg Pathol; 2002 Oct; 26(10):1243-58. PubMed ID: 12360039
[TBL] [Abstract][Full Text] [Related]
20. [Prognosis-related clinicopathologic characteristics of FIGO stage Ⅰ Müllerian adenosarcoma of uterus].
Wang Y; Liu AJ; Chen X; Song X
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):334-338. PubMed ID: 29783798
[No Abstract] [Full Text] [Related]
[Next] [New Search]
